Scott Eric Strome
205 works · 15,310 citations · h-index 56
Top works
- Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
- Erratum: Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
- Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target
- B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma.
- 618: Costimulatory B7-H1 In Renal Cell Carcinoma Patients: Indicator of Tumor Aggressiveness and Potential Therapeutic Target
- B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance
- Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis
- Racial Survival Disparity in Head and Neck Cancer Results from Low Prevalence of Human Papillomavirus Infection in Black Oropharyngeal Cancer Patients
- Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors
- Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors
- Genomic Organization and Expression Analysis of B7-H4, an Immune Inhibitory Molecule of the B7 Family
- Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.
- Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations.
- Characterization of a spontaneously arising murine squamous cell carcinoma (SCC VII) as a prerequisite for head and neck cancer immunotherapy
- The role of the PD-L1:PD-1 pathway in squamous cell carcinoma of the head and neck
- Rat Model for a Vascularized Laryngeal Allograft
- Restoring Immune Function of Tumor-Specific CD4+ T Cells during Recurrence of Melanoma
- Glomus jugulare tumor: Tumor control and complications after stereotactic radiosurgery
- Squamous Cell Carcinoma of the Buccal Mucosa
- Enhanced Therapeutic Potential of Adoptive Immunotherapy by In Vitro CD28/4-1BB Costimulation of Tumor-Reactive T Cells Against a Poorly Immunogenic, Major Histocompatibility Complex Class I-Negative A9P Melanoma